COMBINATION THERAPIES USING AGENTS THAT TARGET TUMOR ASSOCIATED STROMA OR TUMOR CELLS
US Patent 10,758,613
Filed on 2015-06-09
Filed on 2015-06-09
Glypican 2 As A Cancer Marker And Therapeutic Target
Patent Cooperation Treaty
PCT/US2016/060974
Filed on 2016-11-08
PCT/US2016/060974
Filed on 2016-11-08
METHODS FOR DETECTING EXPRESSION OF LNC-FANCI-2 IN CERVICAL CELLS
US Patent 10,487,365
Filed on 2016-09-20
Filed on 2016-09-20
Optimal Dosing Of Heterodimeric Interleukin-15 (IL-15)
US Patent 10,335,460
Filed on 2017-01-24
Filed on 2017-01-24
IL-·15 AND IL-15RALPHA HETERODIMER DOSE ESCALATION REGIMENS FOR TREATING CONDITIONS
Japan
2017-504713
Filed on 2015-07-28
2017-504713
Filed on 2015-07-28
IL-·15 AND IL-15RALPHA HETERODIMER DOSE ESCALATION REGIMENS FOR TREATING CONDITIONS
European Patent
15828027.1
Filed on 2015-07-28
15828027.1
Filed on 2015-07-28